MVJ Medical College And Research Hospital Integrated and Aligned Time table Block -2 Teaching Program - Theory, Practicals Block - 2 01/07/2021 to 30/09/2021 8.30 - Time 11.30 - 12.30 12.30 - 1.30 1.30 - 2.00 2.00 - 4.00 2 TO 3 3 TO 4 4 TO 5 11.30 Lecture/ SGD Date Day clinicals Lecture/SGD class lunch Practicals /SGD/SDL OBG AETCOM SDL SPRTS /ECA class Microbiology Pathology Pharmacology Community Medicine SPORTS /ECA PA18.2 Acute PH 1.20 - Alcohol PH CM 1 PQLI, HDI calculation 1/7/21 THURS Leukemia (L) 1.23 - Drug Deaddiction (L) SGD Ph.1.24.1 physiology of Nephron MI3.1.1 (LECTURE ((SGD 1 )MI3.1.2 01) Introduction to Diarrheagenic E.coli PA 18.1 Non Leukemic 2/7/21 FRI gastrointestinal PA18.2 Chronic Leukemia (L) MI3.1.5 Viral Leucocyte disoreder Pandemic 2.4 infections diarhhea (SGD) IM22.1:- Enumerate the causes of hpercalcemia and distinguish the features of PTH us non PTH mediated hypercalcemia. IM22.2:- Describe the OG14.1 Maternal SU5.1 - Describe normal wound actiology, clinical pelvis: Diameters 3/7/21 SAT healing and factors affecting AETCOM2.4 manifestations, (Clinical pelvimetry healing diagnosis and clinical & Types of pelvis) approach to primary hyperthroidism. IM22.3:- Describe the approach to the management to ypercalcemia 4/7/21 SUN MI3.1.2 ,3,5 AE -3(BATCH A) Diarrheagenic E.coli, cholera,food PH 1.19.58 - 1.19.65 - PA 19.4 Hodgkins Lymphoma & poisoning Hanging drop preperation 5/7/21 MON NEURODEGENERATIVE PA 14 15 MHA & Dimorphic ( Pracs B) MICRO SDL Non Hodgkins Lymphoma (L) MI3.1.7 ,8,9 DOAP: Stool examination DISORDERS (SGD) (3,4,5); Demonstration - EnatamoebaGiardia,Coccidia MI3.1.6 AE MI3.1.3 MI3.1.2 ,3,5 AE -3(BATCH B) 6/7/21 TUE (LECTURE PH 1.24 - DIURETICS (L) Diarrheagenic E.coli, cholera,food PH 3.7 ESSENTIAL DRUGS - Batch A PATHO SDL 02)Cholera poisoning Hanging drop preperation MI3.1.6 (LECTUR MI3.1.7 ,8,9 DOAP: Stool examination CM 1 Concepts of 7/7/21 WED 03)Bacillary dysentery PA 14 15 MHA & Dimorphic ( Pracs A) PH 3.7 ESSENTIAL DRUGS - Batch B COM MED SDL health PA21.1 Normal 8/7/21 THURS Hemostasis & PH 1.24 - DIURETICS (L) CM 1 PQLI, HDI calculation SGD SPORTS /ECA Haemophilia (L) MI3.1.7 (LECTURE MI3.1.9 (SGD 2) 04)Parasitic dysentery Soil transmitted PA21.2 Vascular & Platelet PA 13 Formative 9/7/21 FRI E.histolytica helminthic infections Pandemic 2.4 Disorders (L) assesment (SGD) Balantidium coli MI 3.6 Overview of Acid peptic disorder IM22.4:- Enumerate the components and describe the genetic basis of the multiple endocrine neoplasia syndrome. IM22.5:Enumerate the casuses and describe the clinical features and the OG9.1 Etiology and correct approach to the management of SU5.2 - Elicit, document and diagnosis and abortions including present a history in a patient 10/7/21 SAT menagement of the threatened, AETCOM 2.4 presenting with patint with wounds. incomplete, hyponatremia. inevitable, missed IM22.6:Enumerate the and septic. causes and describe the clinical and laboratory feature and the correct approach to the diagnosis and managment of the patient with hyponatremia. 11/7/21 SUN PH 1.27.1 - 1.27.2 MI3.4 AE (BATCH A)–Lab diagnosis of CATEGORIES OF HTN-JNC PA 21.4 21.5 DIC & Vit K Deficiency Enteric fever 1st week- blood culture 12/7/21 MON 7&8, & PA 16.6 Hemolytic Anemia ( Pracs B) SPORTS /ECA (L) 2nd week widal test PATHOPHYSIOLOGY OF HTN (SGD) MI3.1.8(lecture MI3.4 AE (BATCH B)–Lab diagnosis of 05)Parasitic Diarrhea Enteric fever 1st week- blood culture in immunocompetent PH 1.24.11 - 1.24.17 2nd week widal test 13/7/21 TUE and ANTIDIURETICS & VASOPRESSIN PH 3.7 ESSENTIAL DRUGS - Batch A PATHO SDL immunocompromised ANALOGUES (L) MI3.3(lecture 06) Enteric 14/7/21 WED CM 2 Social health PA 16.6 Hemolytic Anemia ( Pracs A) PH 3.7 ESSENTIAL DRUGS - Batch B fever PH 1.26.1-1.26.2 - RAAS PA22.4 22.5 Blood Components & PH 1.26 - DRUGS ACTING ON RAAS 15/7/21 THURS Transfusion CM 1 Health Indicators SGD MICRO SDL (L) transmitted Infections (L) MI3.5 (lecture 07) MI 3.7. Food poisoning 1(LECTURE 08) PA 22.6 22.7 Transfusion Enterically PA 8.1 Role of 16/7/21 FRI reactions & Autologous Pandemic 2.4 transmitted Viral cytology (SGD) transfusions (L) hepatitis - Hepatitis A and E 17/7/21 SAT 18/7/21 SUN MI3.7 AE : (Batch A) Seromarkers of PH 1.27.17 - 1.27.22 Hepatitis B, Hepatitis C 19/7/21 MON TREATMENT OF SHOCK PA11.1 Genetic Disorders (L) PA 18 Leukemia ( Pracs B) COM MED SDL (SGD) MI 3.7. 2 -(lecture MI3.7 AE : (Batch B) Seromarkers of PH 1.27.6 - 1.27.12 CALCIUM 09) Hepatitis B Hepatitis B, Hepatitis C 20/7/21 TUE CHANNEL BLOCKER & PH 3.5 P drugs- Batch A VASODILATORS (L) CM 3 Nutrition MI 3.7. 3 (Lecture 10) 21/7/21 WED PA 18 Leukemia ( Pracs B) PH 3.5 P drugs - Batch B PATHO SDL and health into Hepatitis C and D PA 11.2 Tumors of PH 1.27.10 - 1.27.13 - 1.27.16 CM 2 IEC and Behavioural change 22/7/21 THURS infancy & childhood TREATMENT OF HTN & HTN communication (BCC) - concept MICRO SDL (L) EMERGENCIES (L) and examples SGD MI4.1.1: (Lecture MI4.1.6 (SGD 3) PA 8.2 PAP smear & 23/7/21 FRI 11) Introduction to PA11.3 Storage disorders (L) Actinomycosis, Pandemic 2.4 anaerobic infections. Nocardia. Body Fluids (SGD) MI4.3.7 Cellulitis IM22.7:-Enumerate the causes and describe the clinical and laboratory features and the correct approach to the diagnosis and managment of the patient with hypokalemia IM22.8:Enumerate the SU5.3 - Differentiate the various causes and describe types of wounds, plan and OG9.5 Hyperemesis 24/7/21 SAT the clinical and AETCOM2.5 observe gravidarum laboratory featuress management of wounds and the correct approch to the diagnosis and management of the patient with hyperkalemia. IM22.9:Enumetate the causes and describe the clinical and laboratory features of metabolic acidosis. 25/7/21 SUN PH 1.28.1 - 1.28.2, (Batch A) Applied bacteriology, virology PA 19 Specimen - Spleenomegaly TB TYPES AND PA12.2 Protrein energy and parasitology exercises in GIT Lymphnode 26/7/21 MON PATHOPHYSIOLOGY OF malnutrition & starvation (L) Slides TB Lymph node Hodgkins Lymphoma ( ANGINA (SGD) Pracs B) MI4.1.2 (Lecture (Batch A) Applied bacteriology, virology PH 1.28.3 - 1.28.10 - NITRATES & PH 3.1 PRESCRIPTION WRITING - Batch 27/7/21 TUE 12)Tetanus and parasitology exercises in GIT COM MED SDL CCBs (L) A PA 19 Specimen - Splenomegaly TB Lymphnode CM 3 Common MI4.1.5 (Lecture 13) PH 3.1 PRESCRIPTION WRITING - Batch 28/7/21 WED Slides TB Lymph node Hodgkins Lymphoma ( SPORTS /ECA nutritional disorders Infections of Nonsporing B Pracs A) anaerobes PH 1.28.11 - 1.28.21 CARDIOPROTECTIVE DRUGS AND CM 1 Concept of causation, germ 29/7/21 THURS PA 12.3 Obesity (L) PERIPHERAL VASCULAR DISEASES theory SGD (L) MI4.2 (Lecture 14) MI4.3.6 (SGD 4) PA 19.1 19.6 19.7 Bone & joint PA 24.1 Oral Cancers & Salivary Tissue nematode Lymphadenopathy 30/7/21 FRI Pandemic 2.4 infections gland tumors (L) infections of skin & Splenomegaly and soft-tissue (SGD) IM22.10:Enumerate the causes of describle the clinical and laboratory features of metabolic alkalosis. IM22.11:Enumerate the causes and describe the clinical and laboratory features of respiratory acidosis. SU 5.4 - Discuss the medicolegal OG10.1.1 APH: 31/7/21 SAT AETCOM2.5 IM22.12:Enmerate the aspects of wound Placenta praevia causes and describe the clinical and laboratory features of respiratory alkalosis IM22.13:Identify the underllying acidebased disorder based on the ABGreport and clincial situation. 1/8/21 SUN MI4.3.1 (BATCH A) Gram stain PH 1.33 exercise Gram stain of Cl.tetaniDemo) PA 24.2 24.3 Peptic Ulcer Disease 2/8/21 MON PHARMACOTHERAPY OF PA 22 Blood Grouping & OSPE(Pracs B) COM MED SDL (L) Demonstration of sample collection, – COUGH (SGD) (collection of pus) AE 3- 1.Cellulitis (Streptococcus pyogenes), 2.Surgical site MI4.3 (Lecture MI4.3.1 (BATCH A) Gram stain PH 3.1 PRESCRIPTION WRITING - Batch 3/8/21 TUE PATHO SDL 15) PH 1.29 DRUGS USED CHF (L) exercise Gram stain of Cl.tetaniDemo) A Introduction to Demonstration of sample collection, – CM 9 Demography MI4.3.2 (Lecture 16) PH 3.1 PRESCRIPTION WRITING - Batch PH 1.30.1 - CARDIAC 4/8/21 WED PA 22 Blood Grouping & OSPE(Pracs A) intoduction Leprosy, (Atypical B ELECTROPHYSIOOGY CM 1. Prevention – Concept, PA24.6 Inflammatory PH 1.30 PHARMACOTHERAPY OF 5/8/21 THURS Levels of prevention, application CARDIAC ARRHYTHMIAS (L) Bowel Diseases (L) of interventions MI4.3.3- (Lecture MI4.3.3a (lecture PA 19.2 Tuberculous 6/8/21 FRI 17) Herpes viruses PA 24.7 CA Colon (L) 18)Viral Pandemic 2.4 lymphadenitis (SGD) exanthematous IM23.1:Discuss and describe the methods of nutritional assessment in an adult and calculation SU 4.1 - Elicit document and of caloric requirements present history in a case of Burns OG10.1.2 APH: 7/8/21 SAT during illnesses.